New York Post Drugmakers to raise US prices on at least 350 medicines despite pressure from Trump
Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance.
Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance.